VIRS

Pacer BioThreat Strategy ETF
VIRS

Overview Fund Activity
Delisted

VIRS was delisted on the 10th of October, 2024.

Back to rankings

6 hedge funds and large institutions have $1.01M invested in Pacer BioThreat Strategy ETF in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Rockefeller Capital Management
Rockefeller Capital Management
New York
+$39K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$28.8K
3
UBS Group
UBS Group
Switzerland
+$932
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$28

Top Sellers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$312K
2
Osaic Holdings
Osaic Holdings
Arizona
-$2K
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$384K +$28.8K +1,021 +8%
Osaic Holdings
2
Osaic Holdings
Arizona
$380K -$2K -71 -0.5%
UBS Group
3
UBS Group
Switzerland
$131K +$932 +33 +0.7%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$73K -$312K -11,119 -81%
Rockefeller Capital Management
5
Rockefeller Capital Management
New York
$39K +$39K +1,403 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$28 +$28 +1 New